Central effects of humanin on hepatic triglyceride secretion

Zhenwei Gong, Kai Su, Lingguang Cui, Emir Tas, Ting Zhang, H. Henry Dong, Shoshana Yakar, Radhika H. Muzumdar

Research output: Contribution to journalArticle

Abstract

Humanin (HN) is an endogenous mitochondria-associated peptide that has been shown to protect against various Alzheimer’s diseaseassociated insults, myocardial ischemia-reperfusion injury, and reactive oxygen species-induced cell death. We have shown previously that HN improves whole body glucose homeostasis by improving insulin sensitivity and increasing glucose-stimulated insulin secretion (GSIS) from the β-cells. Here, we report that intraperitoneal treatment with one of HN analogs, HNG, decreases body weight gain, visceral fat, and hepatic triglyceride (TG) accumulation in high-fat diet-fed mice. The decrease in hepatic TG accumulation is due to increased activity of hepatic microsomal triglyceride transfer protein (MTTP) and increased hepatic TG secretion. Both intravenous (iv) and intracerebroventricular (icv) infusion of HNG acutely increase TG secretion from the liver. Vagotomy blocks the effect on both iv and icv HNG on TG secretion, suggesting that the effects of HNG on hepatic TG flux are centrally mediated. Our data suggest that HN is a new player in central regulation of peripheral lipid metabolism. humanin; triglyceride secretion; hepatic microsomal triglyceride transfer protein; hypothalamus.

Original languageEnglish (US)
Pages (from-to)E283-E292
JournalAmerican Journal of Physiology - Endocrinology and Metabolism
Volume309
Issue number3
DOIs
StatePublished - Aug 5 2015

Fingerprint

Triglycerides
Liver
Intraventricular Infusions
Myocardial Reperfusion Injury
Glucose
Intra-Abdominal Fat
Vagotomy
High Fat Diet
humanin
Reperfusion Injury
Lipid Metabolism
Intravenous Infusions
Hypothalamus
Weight Gain
Myocardial Ischemia
Insulin Resistance
Reactive Oxygen Species
Mitochondria
Homeostasis
Cell Death

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)
  • Endocrinology, Diabetes and Metabolism

Cite this

Gong, Z., Su, K., Cui, L., Tas, E., Zhang, T., Henry Dong, H., ... Muzumdar, R. H. (2015). Central effects of humanin on hepatic triglyceride secretion. American Journal of Physiology - Endocrinology and Metabolism, 309(3), E283-E292. https://doi.org/10.1152/ajpendo.00043.2015

Central effects of humanin on hepatic triglyceride secretion. / Gong, Zhenwei; Su, Kai; Cui, Lingguang; Tas, Emir; Zhang, Ting; Henry Dong, H.; Yakar, Shoshana; Muzumdar, Radhika H.

In: American Journal of Physiology - Endocrinology and Metabolism, Vol. 309, No. 3, 05.08.2015, p. E283-E292.

Research output: Contribution to journalArticle

Gong, Zhenwei ; Su, Kai ; Cui, Lingguang ; Tas, Emir ; Zhang, Ting ; Henry Dong, H. ; Yakar, Shoshana ; Muzumdar, Radhika H. / Central effects of humanin on hepatic triglyceride secretion. In: American Journal of Physiology - Endocrinology and Metabolism. 2015 ; Vol. 309, No. 3. pp. E283-E292.
@article{f23e7319fdcd4730ada627419bcfbccf,
title = "Central effects of humanin on hepatic triglyceride secretion",
abstract = "Humanin (HN) is an endogenous mitochondria-associated peptide that has been shown to protect against various Alzheimer’s diseaseassociated insults, myocardial ischemia-reperfusion injury, and reactive oxygen species-induced cell death. We have shown previously that HN improves whole body glucose homeostasis by improving insulin sensitivity and increasing glucose-stimulated insulin secretion (GSIS) from the β-cells. Here, we report that intraperitoneal treatment with one of HN analogs, HNG, decreases body weight gain, visceral fat, and hepatic triglyceride (TG) accumulation in high-fat diet-fed mice. The decrease in hepatic TG accumulation is due to increased activity of hepatic microsomal triglyceride transfer protein (MTTP) and increased hepatic TG secretion. Both intravenous (iv) and intracerebroventricular (icv) infusion of HNG acutely increase TG secretion from the liver. Vagotomy blocks the effect on both iv and icv HNG on TG secretion, suggesting that the effects of HNG on hepatic TG flux are centrally mediated. Our data suggest that HN is a new player in central regulation of peripheral lipid metabolism. humanin; triglyceride secretion; hepatic microsomal triglyceride transfer protein; hypothalamus.",
author = "Zhenwei Gong and Kai Su and Lingguang Cui and Emir Tas and Ting Zhang and {Henry Dong}, H. and Shoshana Yakar and Muzumdar, {Radhika H.}",
year = "2015",
month = "8",
day = "5",
doi = "10.1152/ajpendo.00043.2015",
language = "English (US)",
volume = "309",
pages = "E283--E292",
journal = "American Journal of Physiology - Endocrinology and Metabolism",
issn = "0193-1849",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - Central effects of humanin on hepatic triglyceride secretion

AU - Gong, Zhenwei

AU - Su, Kai

AU - Cui, Lingguang

AU - Tas, Emir

AU - Zhang, Ting

AU - Henry Dong, H.

AU - Yakar, Shoshana

AU - Muzumdar, Radhika H.

PY - 2015/8/5

Y1 - 2015/8/5

N2 - Humanin (HN) is an endogenous mitochondria-associated peptide that has been shown to protect against various Alzheimer’s diseaseassociated insults, myocardial ischemia-reperfusion injury, and reactive oxygen species-induced cell death. We have shown previously that HN improves whole body glucose homeostasis by improving insulin sensitivity and increasing glucose-stimulated insulin secretion (GSIS) from the β-cells. Here, we report that intraperitoneal treatment with one of HN analogs, HNG, decreases body weight gain, visceral fat, and hepatic triglyceride (TG) accumulation in high-fat diet-fed mice. The decrease in hepatic TG accumulation is due to increased activity of hepatic microsomal triglyceride transfer protein (MTTP) and increased hepatic TG secretion. Both intravenous (iv) and intracerebroventricular (icv) infusion of HNG acutely increase TG secretion from the liver. Vagotomy blocks the effect on both iv and icv HNG on TG secretion, suggesting that the effects of HNG on hepatic TG flux are centrally mediated. Our data suggest that HN is a new player in central regulation of peripheral lipid metabolism. humanin; triglyceride secretion; hepatic microsomal triglyceride transfer protein; hypothalamus.

AB - Humanin (HN) is an endogenous mitochondria-associated peptide that has been shown to protect against various Alzheimer’s diseaseassociated insults, myocardial ischemia-reperfusion injury, and reactive oxygen species-induced cell death. We have shown previously that HN improves whole body glucose homeostasis by improving insulin sensitivity and increasing glucose-stimulated insulin secretion (GSIS) from the β-cells. Here, we report that intraperitoneal treatment with one of HN analogs, HNG, decreases body weight gain, visceral fat, and hepatic triglyceride (TG) accumulation in high-fat diet-fed mice. The decrease in hepatic TG accumulation is due to increased activity of hepatic microsomal triglyceride transfer protein (MTTP) and increased hepatic TG secretion. Both intravenous (iv) and intracerebroventricular (icv) infusion of HNG acutely increase TG secretion from the liver. Vagotomy blocks the effect on both iv and icv HNG on TG secretion, suggesting that the effects of HNG on hepatic TG flux are centrally mediated. Our data suggest that HN is a new player in central regulation of peripheral lipid metabolism. humanin; triglyceride secretion; hepatic microsomal triglyceride transfer protein; hypothalamus.

UR - http://www.scopus.com/inward/record.url?scp=84938595566&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84938595566&partnerID=8YFLogxK

U2 - 10.1152/ajpendo.00043.2015

DO - 10.1152/ajpendo.00043.2015

M3 - Article

C2 - 26058861

AN - SCOPUS:84938595566

VL - 309

SP - E283-E292

JO - American Journal of Physiology - Endocrinology and Metabolism

JF - American Journal of Physiology - Endocrinology and Metabolism

SN - 0193-1849

IS - 3

ER -